BMPR1A and rectal cancer: Two cases were excluded due to benign pathology (juvenile polyposis syndrome associated with BMPR1A gene pathogenic variant and another with serrated polyposis syndrome) leaving 19 cases (85.7%) with rectal malignant neoplasm, including the patient with low rectal neuroendocrine tumor were included in the final analysis.